Romain Banchereau - Genentech Inc, San Francisco, CA 94080 USA

基本信息

Career Trajectory

Bio

I am a computational biologist and translational systems immunologist focused on the immune networks that drive human disease pathogenesis and clinical heterogeneity. I am particularly interested in identifying the molecular networks underlying disease pathogenesis to stratify patients, define personalized treatment strategies and improve clinical trial design.

Research Interests

Papers共 79 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Automated Tumor Immunophenotyping Predicts Clinical Benefit from Anti-Pd-l1 Immunotherapy

Xiao Li,Jeffrey Eastham,Jennifer M. Giltnane,Wei Zou,Andries Zijlstra,Evgeniy Tabatsky,Romain Banchereau,Ching-Wei Chang,Barzin Y. Nabet,Namrata S. Patil,Luciana Molinero, Steve Chui, Maureen Harryman,Shari Lau,Linda Rangell,Yannick Waumans,Mark Kockx,Darya Orlova,Hartmut Koeppen

JOURNAL OF PATHOLOGYno. 2 (2024): 190-202

Cited0Views0WOSBibtex

Immune Heterogeneity in Small-Cell Lung Cancer and Vulnerability to Immune Checkpoint Blockade

CANCER CELLno. 3 (2024)

Cited0Views0WOSBibtex

Circulating Kidney Injury Molecule-1 (KIM-1) Biomarker Analysis in IMmotion010: A Randomized Phase 3 Study of Adjuvant (adj) Atezolizumab (atezo) Vs Placebo (pbo) in Patients (pts) with Renal Cell Carcinoma (RCC) at Increased Risk of Recurrence after Resection

Laurence Albiges,Axel Bex,Cristina Suarez,Robert Uzzo, Xiaobin Tang, Zoe June Assaf,Sarita Dubey, Erik T. Goluboff, Corey Carter,Romain Banchereau,Mahrukh A. Huseni,Sumanta Kumar Pal,Brian I. Rini

Journal of Clinical Oncologyno. 16_suppl (2024): 4506-4506

Cited0Views0Bibtex

Association of Machine Learning (ml)–derived Histological Features with Transcriptomic Molecular Subtypes in Advanced Renal Cell Carcinoma (RCC)

Niha Beig,Shima Nofallah,David F. McDermott,Robert J. Motzer,Thomas Powles,Brian I. Rini, Hartmut Koeppen,Romain Banchereau,Miles Markey,Isaac Finberg, Geetika Singh,Limin Yu,Robert Egger,Chintan Parmar,Jake Conway,Stephanie Hennek,Daniel Ruderman,Samuel Vilchez,Mahrukh A. Huseni,Jennifer Margaret Giltnane

Journal of Clinical Oncologyno. 16_suppl (2024): 4519-4519

Cited0Views0Bibtex

Predictive Value of Dynamic Changes in Ctdna and Baseline Biomarkers with Neoadjuvant Atezolizumab in Operable Urothelial Carcinoma in the ABACUS Trial

Matthew Nicholas Young,Bernadett Szabados,Zoe Assaf,Francesca Jackson-Spence,Elizabeth Nally,Connor Wells,Cristina Suarez,Daniel Castellano,Thomas Powles,Romain Banchereau

JOURNAL OF CLINICAL ONCOLOGYno. 4_SUPPL (2024): 534-534

Cited0Views0Bibtex

Supplementary Figure from Clinico-Genomic Characterization of Patients with Metastatic Urothelial Carcinoma in Real-World Practice Identifies a Novel Bladder Immune Performance Index (BIPI)

Bernadett Szabados,Mariano Ponz-Sarvisé,Robson Machado,Diego Saldana,Edward E. Kadel,Romain Banchereau,Fanny Bouquet, Marius Garmhausen,Thomas Powles,Carsten Schröder

crossref（2023）

Cited0Views0Bibtex

Supplementary Table 3 from Reprogramming Tumor-Infiltrating Dendritic Cells for CD103+CD8+ Mucosal T-cell Differentiation and Breast Cancer Rejection

Te-Chia Wu,Kangling Xu,Romain Banchereau,Florentina Marches,Chun I. Yu,Jan Martinek,Esperanza Anguiano,Alexander Pedroza-Gonzalez,G. Jackson Snipes, Joyce O'Shaughnessy,Stephen Nishimura,Yong-Jun Liu,Virginia Pascual,Jacques Banchereau,Sangkon Oh,Karolina Palucka

crossref（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn